Skip to Main Content
1-877-YALEMDS
1-877-YALEMDS
Phase III

A Phase 3 Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lutikizumab in Adult and Adolescent Subjects with Moderate to Severe Hidradenitis Suppurativa

  • Study IRB#:2000037428
  • Last Updated:07/12/2026

    Contact Us

    For more information about this study, including how to volunteer, contact:

    Christopher Bunick

    Help Us Discover!

    You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.

    CREATE A VOLUNTEER PROFILE

    Principal Investigator

    Sub-Investigator

    For more information about this study, including how to volunteer, contact:

    Christopher Bunick